SMART PH4H
0.1.0 - ci-build

SMART PH4H, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-ph4h/tree/main and changes regularly. See the Directory of published versions

Example Bundle: Example SMART IPS

Document Subject

Generated Narrative: Patient 2b90dd2b-2dab-4c75-9bb9-a355e07401e8

Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583)

Active:true
Contact Detail
mother:

Document Content

Resource "30551ce1-5a28-4356-b684-1e639094ad4d"

identifier: id: 3f69e0a5-2177-4540-baab-7a5d0877428f

status: final

type: Patient summary Document (LOINC#60591-5)

date: 2017-12-11 02:30:00+0100

author: Beetje van Hulp, MD

title: Patient Summary as of December 11, 2017 14:30

confidentiality: N

attester

mode: legal

time: 2017-12-11 02:30:00+0100

party: Beetje van Hulp, MD

attester

mode: legal

time: 2017-12-11 02:30:00+0100

party: Anorg Aniza Tion BV

custodian: Anorg Aniza Tion BV

RelatesTos

-CodeTarget[x]
*appendsid: c2277753-9f90-4a95-8ddb-a0b3f6e7d292

Events

-CodePeriod
*care provision (ActClass#PCPR)?? --> 2017-12-11 02:30:00+0100

Medication

MedicationStrengthFormDosageComment
Anastrozole1 mgtabletonce dailytreatment for breast cancer
Black Cohosh Extractpilherbal supplement

Allergies and Intolerances

Allergy to penicillin, high criticality

Active Problems

Hot flushes

Advance Directives

Consent MYS for pilgrimage

History of Past Illness

Breast cancer Stage II with no evidence of recurrence following treatment

Plan of Treatment

Continue hormone medication with Anastrozole for total of 5 years and monitor for potential breast cancer recurrence

Results

Blood typing
Blood groupA+
C Ab [Presence] in Serum or PlasmaPositive
E Ab [Presence] in Serum or PlasmaPositive
Little c Ab [Presence] in Serum or PlasmaNegative
Hemoglobin A1c monitoring
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC7.5 %
Bacteriology
Methicillin resistant Staphylococcus aureus
Healthy carrier of MRSA

Additional Resources Included in Document

Entry 1 - fullUrl = urn:uuid:30551ce1-5a28-4356-b684-1e639094ad4d

Resource Composition:

Resource "30551ce1-5a28-4356-b684-1e639094ad4d"

identifier: id: 3f69e0a5-2177-4540-baab-7a5d0877428f

status: final

type: Patient summary Document (LOINC#60591-5)

date: 2017-12-11 02:30:00+0100

author: Beetje van Hulp, MD

title: Patient Summary as of December 11, 2017 14:30

confidentiality: N

attester

mode: legal

time: 2017-12-11 02:30:00+0100

party: Beetje van Hulp, MD

attester

mode: legal

time: 2017-12-11 02:30:00+0100

party: Anorg Aniza Tion BV

custodian: Anorg Aniza Tion BV

RelatesTos

-CodeTarget[x]
*appendsid: c2277753-9f90-4a95-8ddb-a0b3f6e7d292

Events

-CodePeriod
*care provision (ActClass#PCPR)?? --> 2017-12-11 02:30:00+0100

Entry 2 - fullUrl = urn:uuid:2b90dd2b-2dab-4c75-9bb9-a355e07401e8

Resource Patient:

Generated Narrative: Patient 2b90dd2b-2dab-4c75-9bb9-a355e07401e8

Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583)

Active:true
Contact Detail
mother:

Entry 3 - fullUrl = urn:uuid:1c616b24-3895-48c4-9a02-9a64110351ef

Resource Practitioner:

Generated Narrative: Practitioner 1c616b24-3895-48c4-9a02-9a64110351ef

identifier: urn:oid:2.16.528.1.1007.3.1/129854633

active: true

name: Beetje van Hulp

Qualifications

-Code
*Doctor of Medicine

Entry 4 - fullUrl = urn:uuid:890751f4-2924-4636-bab7-efffc7f3cf15

Resource Organization:

Generated Narrative: Organization 890751f4-2924-4636-bab7-efffc7f3cf15

identifier: urn:oid:2.16.528.1.1007.3.3/564738757

active: true

name: Anorg Aniza Tion BV / The best custodian ever

Contacts

-TelecomAddress
*+31-51-34343400Houttuinen 27 Dordrecht 3311 CE NL (work)

Entry 5 - fullUrl = urn:uuid:c64139e7-f02d-409c-bf34-75e8bf23bc80

Resource Condition:

Generated Narrative: Condition c64139e7-f02d-409c-bf34-75e8bf23bc80

identifier: urn:oid:1.2.3.999/c87bf51c-e53c-4bfe-b8b7-aa62bdd93002

clinicalStatus: Active

verificationStatus: Confirmed

category: Problem

severity: Moderate

code: Menopausal flushing (finding)

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

onset: 2015

recordedDate: 2016-10

Entry 6 - fullUrl = urn:uuid:c220e36c-eb67-4fc4-9ba1-2fabc52acec6

Resource MedicationStatement:

Generated Narrative: MedicationStatement c220e36c-eb67-4fc4-9ba1-2fabc52acec6

identifier: urn:oid:1.2.3.999/b75f92cb-61d4-469a-9387-df5ef70d25f0

status: recorded

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-03 --> (ongoing)

dosage

Entry 7 - fullUrl = urn:uuid:47524493-846a-4a26-bae2-4ab03e60f02e

Resource MedicationStatement:

Generated Narrative: MedicationStatement 47524493-846a-4a26-bae2-4ab03e60f02e

identifier: urn:oid:1.2.3.999/9e312d6b-c6b6-439a-a730-6efaa5dcf8bc

status: recorded

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2016-01 --> (ongoing)

Dosages

-Route
*Oral use

Entry 8 - fullUrl = urn:uuid:976d0804-cae0-45ae-afe3-a19f3ceba6bc

Resource Medication:

Generated Narrative: Medication 976d0804-cae0-45ae-afe3-a19f3ceba6bc

code: Product containing anastrozole (medicinal product)

Entry 9 - fullUrl = urn:uuid:8adc0999-9468-4ac9-9557-680fa133d626

Resource Medication:

Generated Narrative: Medication 8adc0999-9468-4ac9-9557-680fa133d626

code: Black Cohosh Extract herbal supplement

Entry 10 - fullUrl = urn:uuid:72884cad-ebe6-4f43-a51a-2f978275f132

Resource AllergyIntolerance:

Generated Narrative: AllergyIntolerance 72884cad-ebe6-4f43-a51a-2f978275f132

Abatement: 2010

clinicalStatus: Active

verificationStatus: Confirmed

type: Allergy

category: Medication

criticality: High Risk

code: Substance with penicillin structure and antibacterial mechanism of action (substance)

patient: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

onset: Absent because : unknown

Entry 11 - fullUrl = urn:uuid:c4597aa2-688a-401b-a658-70acc6de28c6

Resource Condition:

Generated Narrative: Condition c4597aa2-688a-401b-a658-70acc6de28c6

identifier: urn:oid:1.2.3.999/66d4a8c7-9081-43e0-a63f-489c2ae6edd6

clinicalStatus: Remission

verificationStatus: Confirmed

category: Problem

severity: Severe

code: Malignant tumor of breast

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

onset: 2015-01

abatement: 2015-03

Entry 12 - fullUrl = urn:uuid:45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7

Resource Organization:

Generated Narrative: Organization 45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7

active: true

type: Other

name: Laboratoire de charme

Entry 13 - fullUrl = urn:uuid:aa11a2be-3e36-4be7-b58a-6fc3dace2741

Resource Observation:

Generated Narrative: Observation aa11a2be-3e36-4be7-b58a-6fc3dace2741

status: Final

category: Laboratory

code: ABO and Rh group [Type] in Blood

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-10-10 09:15:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: Blood group A Rh(D) positive

Entry 14 - fullUrl = urn:uuid:6e39ccf3-f997-4a2b-8f28-b4b71c778c70

Resource Observation:

Generated Narrative: Observation 6e39ccf3-f997-4a2b-8f28-b4b71c778c70

status: Final

category: Laboratory

code: C Ab [Presence] in Serum or Plasma

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-10-10 09:35:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: Positive

Entry 15 - fullUrl = urn:uuid:b4916505-a06b-460c-9be8-011609282457

Resource Observation:

Generated Narrative: Observation b4916505-a06b-460c-9be8-011609282457

status: Final

category: Laboratory

code: E Ab [Presence] in Serum or Plasma

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-10-10 09:35:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: Positive

Entry 16 - fullUrl = urn:uuid:a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4

Resource Observation:

Generated Narrative: Observation a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4

status: Final

category: Laboratory

code: little c Ab [Presence] in Serum or Plasma

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-10-10 09:35:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: Negative

Entry 17 - fullUrl = urn:uuid:2639657a-c19a-48e2-82cc-471e13b8ad94

Resource Observation:

Generated Narrative: Observation 2639657a-c19a-48e2-82cc-471e13b8ad94

status: Final

category: Laboratory

code: Blood typing

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2015-10-10

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

hasMember:

Entry 18 - fullUrl = urn:uuid:cc354e00-a419-47ea-8b6c-1768b2a01646

Resource Observation:

Generated Narrative: Observation cc354e00-a419-47ea-8b6c-1768b2a01646

status: Final

category: Laboratory

code: Hemoglobin A1c/Hemoglobin.total in Blood by HPLC

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2017-11-10 08:20:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: 7.5 % (Details: UCUM code% = '%')

note: Above stated goal of 7.0 %

Entry 19 - fullUrl = urn:uuid:26bee0a9-5997-4557-ab9d-c6adbb05b572

Resource Observation:

Generated Narrative: Observation 26bee0a9-5997-4557-ab9d-c6adbb05b572

status: Final

category: Laboratory

code: Bacteria identified in Isolate

subject: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

effective: 2017-12-10 08:20:00+0100

performer: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#175bd032-8b00-4728-b2dc-748bb1501aed; type = document; timestamp = 2024-02-11 11:32:00+0100

value: Methicillin resistant Staphylococcus aureus

note: Healthy carrier of MRSA

Entry 20 - fullUrl = urn:uuid:c7781f44-6df8-4a8b-9e06-0b34263a47c7

Resource Consent:

Generated Narrative: Consent c7781f44-6df8-4a8b-9e06-0b34263a47c7

status: Active

category: Advance Directive

Provisions

-PeriodPurpose
*1964-01-01 --> 2016-01-01ActReason COC: coordination of care